11
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Anti-infectives: Overview Pradimicins: Potential antifungal and anti-HIV agents

&
Pages 1483-1491 | Published online: 03 Mar 2008

References to Primarv Literaturess

  • OKI T, KONISHI M, TOMATSU K, TOMITA K, SAITOH K, TSUNAKAWA M, NISHIO M, MIYAKI T, KAWAGUCHI H: Pradimicin, a novel class of potent antifungal antibiot-ics. J Antibiotics (1988) 41: 1701–1704.
  • OKI T, SAITOH K, TOMATSU K, TOMITA K, KONISHI M, KAWAGUCHI H: Novel antifungal antibiotic BMY-28567: structural study and biological activities. Ann. IVY Acad. Sci. (1988) 544: 184–187.
  • TAKEUCHI T, HARA T, NAGANAWA H, OKADA M, HAMADA M, UMEZAWA H, GOMI S, SEZAKI M, KONDO S: New antifungal antibiotics, benanomicins A and B from an actinomycete. J. Antibiotics (1988) 41: 807–811.
  • UEKI T, NUMATA K, SAWADA Y, NAKAYAMA T, FUICA-GAWA Y, OKI T: Studies on the mode of antifungal action of pradimicin antibiotics. L Lectin-mimic binding of BMY-28864 to yeast matman in the presence of calcium. J. Antibiotics (1993) 46: 149–161.
  • SAWADA Y, NUMATA K, MURAKAMI T, TANIMICHI H, YAMAMOTO S, OKI T: Calcium-dependant anticandidal activity of BMY-28864, a new water-soluble pradimicin derivative. J. Antibiotics (1990) 43: 715–721.
  • SAWADA Y, MURAKAMI T, UEKI T, FUKAGAWA Y, OKI T, NOZAWA Y: Mannan-mediated anticandidal activity of BMY-28864, a new water-soluble pradimicin derivative. J. Antibiotics (1991) 44: 119–121.
  • UEKI T, NUMATA K, SAWADA Y, NISHIO M, OHKUMA H, TODA S, KAMACHI H, FUKAGAWA Y, OKI T: Studies on the mode of antifungal action of pradhnicin antibiotics. U. D-Mannopyranoside-binding site and calcium bind-ing site. J. Antibiotics (1993) 43: 455–464.
  • UEKI T, OKA M, FUKAGAWA Y, OKI T: Studies on the mode of antifungal action of pradimicin antibiotics. M. Spectrophotometric sequence analysis of the ternary complex formation of BMY-28864 with D-mannopyra-noskle and calcium. j. Antibiotics (1993) 46: 465–477.
  • TANABE A, NAICASHIMA H, YOSHIDA 0, YAMAMOTO N, TENMYO 0, OKI T: Inhibitory effect of new antibiotic, pradimicin A on infectivity, cytopathic effect and rep-lication of human immunodeficiency virus in vitro. J. Antibiotics (1988) 41: 1708–1710.
  • TANABE-TOCHIKURA A, TOCHIKURA T, YOSHIDA 0, OKI T, YAMAMOTO N: Pradimicin A inhibition of human immunodeficiency virus: attenuation by mannan. Virol. (1990) 176: 467–473.
  • MURAKAMI T, NAKASHIMA H, ITO M, YAMAMOTO N: Anovel cocuhure system for evaluating anti-HIV drugs. AIDS (1992) 6: 1279–1285.
  • OKI T: A new family of antibiotics:benzofalnaphthacenequinones - a water soluble pradimicin derivative, BMY-28864. In: Recent Progress in Antifungal Chemotherapy', Marcel Dekker, Inc., (1991) 381–391.
  • FUKAGAWA Y, UEKI T, NUMATA K, OKI T: Pradimicins and benanoraicins, sugar-recognizing antibiotics: their novel mode of antifungal action and conceptual signifi-cance. Actinomycetol. (1993) 7: 1–22.
  • TOMITA K, NISHIO M, SAITOH K, YAMAMOTO H, HOSHINO Y, OHKUMA H, KONISHI M, MIYAKI T, OKI T: Pradimicins A, B and C: new antifungal antibiotics. L Taxonomy, production, isolation, and physico-cherol-cal properties. J. Antibiotics (1990) 43: 755–762.
  • OKI T, TENMYO 0, HIRANO M, TOMATSU K, KAMEI H:Pradimicins A, B and C: New antifungal antibiotics. II. In vitro and in vivo biological activities. J. Antibiotics (1990) 43: 763–770.
  • SAWADA Y, NISHIO M, YAMAMOTO H, HATORI M, MIYAKIT, KONISHI M, OKI T: New antifungal antibiotics, pradirnicins D and E. Glycine analogs of pradimlcins A and C. J. Antibiotics (1990) 43: 771–777.
  • SAWADA Y, HATORI M, YAMAMOTO H, NISHIO M, MIYAKIT, OKI T: New antifungal antibiotics pradimicins FA-1 and FA-2: D-serine analog of pradimicins A and C. J. Antibiotics (1990) 43: 1223–1229.
  • KAKUSHIMA M, NISHIO M, NUMATA K, KONISHI M, OKIT: Effect of stereochemistry at the C-17 position on the antifungal activity of pradimicin A. J. Antibiotics (1990) 43: 1028–1030.
  • OKI T, KAKUSHIMA M, NISHIO M, KAMEI H, HIRANO M,SAWADA Y, KONISHI M: Water-soluble pradimicin de-rivatives, synthesis and antifungal evaluation of N, N-cihnethyl pradimicins. I Antibiotics (1990) 43: 1230–1235.
  • SAWADA Y, TSUNO T, YAMAMOTO H, NISHIO M, KONISHI M, OKI T: Pradimicins M, N, 0, and P, new dihy-drobenzo[ahraphthacenequinones produced by blocked mutants of Actinontadura bibisca P157-2. J. Antibiotics (1990) 43: 1267–1374.
  • KAKUSHIMA M, MASUYOSHI S, HIRANO M, SHINODA M,OHTA A, KAMEI H, OKI T: In vitro and in vivo antifungal activities of BMY-28864, a water-soluble pradimicin derivative. Antirnicrob. Agents Cbemotber. (1991) 35: 2185–2190.
  • KAMACHI H, IIMURA S, OKUYAMA S, HOSHI H, TAMURA S, SHINODA M, SAITOH K, KONISHI M, OKI T: Synthesis and antifungal activities of pradimicin derivatives. Modification at C4'-position. J. Antibiotics (1992) 45: 1518–1525.
  • OKI T, KAKUSHIMA M, HIRANO M, TAKAHASHI A, OHTA A, MASUYOSHI S, HATORI M, KAMEI H: In vitro and invivo antifungal activities of BMS-181184. J. Antibiotics (1992) 45: 1512–1517
  • SAWADA Y, TSUNO T, UEKI T, YAMAMOTO H, FUICA-GAWA Y, OKI T: Pradhnicin Q, a new pradimicin agly-cone, with a-p,lucosidase inhibitory activity./ Antibiotics (1993)46:507–510.
  • NISHIO M, OHICUMA H, KAKUSHIMA M, OHTA S, IIMURA S, HIRANO M, KONISHI M, OKI T: Synthesis and antifun-gal activities of pradimicin A derivatives. Modification of the alanine moiety. J. Antibiotics (1993) 46: 494–499. FURUMAI T, SAITOH K, KAKUSHIMA M, YAMAMOTO S, SUZUKI K, IKEDA C, KOBARU S, HATORI M, OKI T: BMS-181184, a new pradimicin derivative. Screening, taxonomy, directed biosynthesis, isolation and charac-terization. J. Antibiotics (1993) 46: 265–274
  • SAITOH K, SAWADA Y, TOMITA K, TSUNO T, HATORI M,OKI T: Pradimicins L and FL: new pradimicin conge-ners from Actinomadura vertitcospora subsp. neo-hibisca. J. Antibiotics (1993) 46: 387–397.
  • SAITOH K, TENMYO 0, YAMAMOTO 5, FURUMAI T, OKIT: Pradimicins S, a new pradimicin analog. L Taxon-omy, fermentation and biological activities./ Antibiotics (1993) 46: 580–588.
  • SAITOH K, TSUNO T, KAKUSHIMA M, HATORI M, FURUMAI T, OKI T: Pradimicin S, a new pradhnicin analog. IL Isolation and structure elucidation. J. Antibiotics (1993) 46:406–411.
  • ABURAKI S, YAMASHITA H, OHNUMA T, KAMACHI H, MORIYAMA T, MASUYOSHI S, KAMEI H, KONISHI M, OKI T: Antifungal activities of pradimicin derivatives. Modi-fications of the sugar part. J. Antibiotics (1993) 46:631–640.
  • ABURAKI S, OKUYAMA S, HOSHI H, KAMACHI H, NISHIO M, HASEGAWA T, MASUYOSHI S, KONISHI M, OKI T: Synthesis and antifungal activity of pradimicin deriva-tives. Modification on the aglycone part. J. Antibiotics (1993) 46: 1447–1457.
  • OKUYAMA S, KAKUSHIMA M, KAMACHI H, KONISHI M,OKI T: Synthesis of alanine-exchanged analogs of pradimicin A. J. Antibiotics (1993) 46: 500–506.
  • SAITOH K, SUZUKI K, HIRANO M, FURUMAI T, OKI T:Pradimicins FS and FB, new pradimicin analogs: Di-rected production, structures and biological activities. J. Antibiotics (1993) 46: 398–405.
  • KAMACHI H, OKUYAMA S,HIRANO M, MASUYOSHI S, KONISHI M, OKI T: Antffungal activities of pradimicin derivatives, modifies at C4-amino group. J. Antibiotics (1993) 46: 1246–1251.
  • FURUMAI T, KAKINUMA S, YAMAMOTO H, KOMIYAMA N,SUZUKI K, SAITOH K, OKI T: Biosynthesis of the pradimi-cin family of antibiotics. L Generation and selection of pradimicin non-producing mutants. J. Antibiotics (1993) 46: 412–419.
  • TSUNO T, YAMAMOTO H, NARITA Y, SUZUKI K, HASEGAWA T, KAKINUMA S, SAITOH K, FURUMAI T, OKI T: Biosynthesis of the pradimidn family of antibiotics. H Fermentation, isolation and structure determination of metabolites associated with the pradimicins biosyn-thesis. I Antibiotics (1993) 46: 420–429.
  • FURUMAI T, HASEGAWA T, KAKINUMA M, YAMAMOTO H,SUZUKI K, YAMAMOTO S, HIRANO M, OKI T: Pradimidns Ti and T2, new antifungal antibiotics produced by an actinomycete. L Taxonomy, production, isolation and biological activities. J. Antibiotics (1993) 46: 265–274.
  • HASEGAWA T, KAKINUMA M, HATORI M, ABURAKI S, SAITOH K, FURUMAI T, 01U T: Pradimicins Ti and T2, new antifungal antibiotics produced by an actinomy-cete. IL Physico-chemical properties and structure de-termination. I Antibiotics (1993) 46: 598–605.
  • FURUMAI T, YAMAMOTO H, NARITA Y, HASEGAWA T, ABURAIU S, KAKUSHIMA M, OKI T: Microbial modifica-tion of pradimicins at C-11 leading to 11-0-demethyl-and 11-0-L-xylosylpradimicins A and FAL J. Antibiotics (1993) 46: 1589–1597.
  • HIRANO M, KAKUSHIMA M, TAKAHASHI A, TAMAOICA M,KAMEI H, OKI T: In vivo efficacies of pradimicin deriva-tives, BMS-181184 and BMY-28864, and benanomicin A against systemic Candida albicans and Aspergillus fu-migatus infection in neutropenic mice. Jpn. J. Med. Mycol. (1993) 34: 471–476. References to Patent Literature
  • BRISTOL-MYERS SQUIBB CO, US4870165 (1989).
  • BRISTOL-MYERS SQUIBB CO, US4990497 (1991)
  • a. BISEIBUTU KAGAKU KEN, JP277692 (1987).
  • b. BISEIBUTU KAGAKU KEN, US5055453 (1991).
  • BISEIBUTU KAGAKU KEN, JP206346 (1988).
  • BRISTOL-MYERS SQUIBB CO, W09301820-A (1993)•
  • BRISTOL-MYERS SQUIBB CO, US4992425 (1991).
  • BRISTOL-MYERS SQUIBB CO, US5096817 (1992).
  • BRISTOL-MYERS SQUIBB CO, US4960755 (1990).
  • BRISTOL-MYERS SQUIBB CO, US 4973693 (1990). •
  • BRISTOL-MYERS SQUIBB CO, US506124 (1991).
  • BRISTOL-MYERS SQUIBB CO, US5053395 (1991).
  • BRISTOL-MYERS SQUIBB CO, US5227370 (1993).
  • BRISTOL-MYERS SQUIBB CO, US440060 (1989).
  • BRISTOL-MYERS SQUIBB CO, U5589728 (1990)
  • BRISTOL-MYERS SQUIBB CO, US590621 (1990).
  • BRISTOL-MYERS SQUIBB CO, US5091418 (1992).
  • BRISTOL-MYERS SQUIBB CO, US706668 (1991).
  • BRISTOL-MYERS SQUIBB CO, US853480 (1992).
  • BRISTOL-MYERS SQUIBB CO, EP-580480-A (1994).
  • BRISTOL-MYERS SQUIBB CO, US5194371 (1993).
  • BRISTOL-MYERS SQUIBB CO, US920408 (1992).
  • BRISTOL-MYERS SQUIBB CO, US929931 (1992).
  • BRISTOL-MYERS SQUIBB CO, US983004 (1992).
  • BRISTOL-MYERS SQUIBB CO, EP–584014–A.
  • BISEIKUTU KAGAKU KEN, JP327163 (1987).
  • BISEIKUTU KAGAKU KEN, JP232185 (1988).
  • BISEIKUTU KAGAKU KEN, JP4701 (1989).
  • BISEIKUTU KAGAKU KEN, JP248143 (1989).
  • BISEIKUTU KAGAKU KEN, JP61254 (1990).
  • BISEIKUTU KAGAKU KEN, JP96317 (1990).
  • BISEIKUTU KAGAKU KEN, JP38645 (1991).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.